Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Dec;14(6):667-75.
doi: 10.1007/s11920-012-0319-2.

Staging and neuroprogression in bipolar disorder

Affiliations
Review

Staging and neuroprogression in bipolar disorder

Gabriel Rodrigo Fries et al. Curr Psychiatry Rep. 2012 Dec.

Abstract

The apparently progressive nature of a considerable proportion of cases of bipolar disorder (BD) has been acknowledged in recently proposed clinical staging models. This has been part of an attempt to facilitate and refine diagnosis, treatment selection, and establish a prognosis. The study of the progressive nature of some cases of BD has given raise to the hypothesis of neuroprogression, which postulates that different stages of BD are associated with distinct neurobiological underpinnings. Given that BD may be intimately associated with chronic stress response and coping mechanisms over the course of illness, we propose that cellular resilience mechanisms may play a key role in the neuroprogression in BD. In the present study, we review neuroanatomical evidence of the progression that occurs in many cases of BD, as well as cellular resilience mechanisms and peripheral biomarkers associated with distinct stages of this disorder. In summary, cellular resilience mechanisms seem to be less efficient at later stages of BD, especially mitochondrial and endoplasmic reticulum-related responses to stress. These insights may help in developing staging models of BD, with a special emphasis on the search for biomarkers associated with illness progression.

PubMed Disclaimer

References

    1. Mol Psychiatry. 2005 Jan;10(1):105-16 - PubMed
    1. Biol Psychiatry. 2009 Mar 15;65(6):489-94 - PubMed
    1. Neurosci Biobehav Rev. 2011 Jan;35(3):804-17 - PubMed
    1. Psychol Med. 2007 May;37(5):699-704 - PubMed
    1. J Psychiatr Res. 2011 Aug;45(8):995-1004 - PubMed

Publication types